Evidence map›Paper›PMID 28916738›Full record

ArticleScientific reports2017

Cold atmospheric helium plasma causes synergistic enhancement in cell death with hyperthermia and an additive enhancement with radiation.

Rohan Moniruzzaman, Mati Ur Rehman, Qing-Li Zhao, Paras Jawaid, Keigo Takeda, Kenji Ishikawa, Masaru Hori, Kei Tomihara, Kyo Noguchi, Takashi Kondo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. ROS from Physical Plasmas: Redox Chemistry for Biomedical Therapy.Oxidative medicine and cellular longevity · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Rohan MoniruzzamanDepartment of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Sugitani 2630, Toyama, 930-0194, Japan.
Mati Ur RehmanDepartment of Radiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Sugitani 2630, Toyama, 930-0194, Japan. rehman.mu84@yahoo.com.
Qing-Li ZhaoDepartment of Radiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Sugitani 2630, Toyama, 930-0194, Japan.
Paras JawaidDepartment of Radiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Sugitani 2630, Toyama, 930-0194, Japan.
Keigo TakedaInstitute of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 4648603, Japan.
Kenji IshikawaInstitute of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 4648603, Japan.
Masaru HoriInstitute of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 4648603, Japan.
Kei TomiharaDepartment of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Sugitani 2630, Toyama, 930-0194, Japan.
Kyo NoguchiDepartment of Radiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Sugitani 2630, Toyama, 930-0194, Japan.ORCID 0000-0002-6305-8045
Takashi KondoDepartment of Radiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Sugitani 2630, Toyama, 930-0194, Japan.
Makoto NoguchiDepartment of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Sugitani 2630, Toyama, 930-0194, Japan.
University of Toyama · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold atmospheric plasmas (CAPs) have been proposed as a novel therapeutic method for its anti-cancer potential. However, its biological effects in combination with other physical modalities remain elusive. Therefore, this study examined the effects of cold atmospheric helium plasma (He-CAP) in combination with hyperthermia (HT) 42 °C or radiation 5 Gy. Synergistic enhancement in the cell death with HT and an additive enhancement with radiation were observed following He-CAP treatment. The synergistic effects were accompanied by increased intracellular reactive oxygen species (ROS) production. Hydrogen peroxide (H

Indexed as

Antineoplastic AgentsCell Line, TumorCell SurvivalEpithelial CellsHeliumHot TemperatureHumansLymphocytesPlasma GasesRadiationReactive Oxygen SpeciesAntineoplastic AgentsHeliumPlasma GasesReactive Oxygen Species

Identifiers

PMID28916738
PMCPMC5600975
OpenAlexW2755512227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.